In a New York Times op-ed, the presidents of four historically Black universities and medical schools argue that the lack of racial diversity in clinical trials for a potential coronavirus vaccine “creates problems on two fronts: treatment and trust." To discuss, Jim Braude was joined by one of the authors, Dr. Valerie Montgomery Rice, the president of Morehouse School of Medicine.
